Phase II Trial of Intra-Arterial Chemotherapy using a Novel Lipophilic Platinum Derivative (SM-11355) in Patients with Hepatocellular Carcinoma

By Okusaka Takuji   Okada Shuichi   Nakanishi Toshio   Fujiyama Shigetoshi   Kubo Yasuhiko  

Investigational New Drugs, Vol. 22, Iss. 2, 2004-04 ,pp. : 169-176

Springer Publishing Company

Access to resources Recommend Favorite

Phase II trial of nolatrexed dihydrochloride [Thymitaq^TM, AG 337] in patients with advanced hepatocellular carcinoma

By Jhawer Minaxi   Rosen Lee   Dancey Janet   Hochster Howard   Hamburg Solomon   Tempero Margaret   Clendeninn Neil   Mani Sridhar  

Investigational New Drugs, Vol. 25, Iss. 1, 2007-02 ,pp. : 85-94

Springer Publishing Company

Access to resources Recommend Favorite

Phase II study of darinaparsin in patients with advanced hepatocellular carcinoma

By Wu Jennifer   Henderson Charles   Feun Lynn   Veldhuizen Peter   Gold Philip   Zheng Hui   Ryan Theresa   Blaszkowsky Lawrence   Chen HaoBin   Costa Max   Rosenzweig Barry   Nierodzik MaryLynn   Hochster Howard   Muggia Franco   Abbadessa Giovanni   Lewis Jonathan   Zhu Andrew  

Investigational New Drugs, Vol. 28, Iss. 5, 2010-10 ,pp. : 670-676

Springer Publishing Company

Access to resources Recommend Favorite

Phase II trial of imatinib (Gleevec®) in patients with metastatic renal cell carcinoma

By Vuky Jacqueline   Isacson Christina   Fotoohi Mehran   Cruz Jason   Otero Henry   Picozzi Vincent   Malpass Thomas   Aboulafia David   Jacobs Andrew  

Investigational New Drugs, Vol. 24, Iss. 1, 2006-01 ,pp. : 85-88

Springer Publishing Company

Access to resources Recommend Favorite

Randomized clinical control study of locoregional therapy combined with arsenic trioxide for the treatment of hepatocellular carcinoma

By  

Cancer, Vol. 121, Iss. 17, 2015-09 ,pp. : 2917-2925

Blackwell Publishing

Access to resources Recommend Favorite